15 February 2021 Priya Vaidya 743 Case Updates Neurim Pharmaceuticals v Generics UK Limited [2020] EWHC 3270 (Pat) byPriya Vaidya The case: A patent case relating to prolonged release pharmaceutical formulations in which the active ingredient melatonin is intended to improve the restorative quality of sleep in a patient suffering from primary insomnia characterised by non-restorative sleep. The case called for experts in sleep medicine. To continue reading you must be an EWI member, become a member and access exclusive content. Already a member? Login Share Print Tags Bias05. Rules and Regulations10. Report Writing Related articles T (Fresh Evidence on Appeal), Re [2024] EWCA Civ 1384 Is it within the remit of an expert to decide which witness of fact they believe or disbelieve? When the joint statement is no more than really two statements, one from each expert. The dangers of a considerable burden of expert work Preliminary (pre-report) experts’ meetings Switch article R (IJ (Kosovo)) v Secretary of State for the Home Department [2020] EWHC 3487 (Admin) Previous Article B v A [2020] EWHC 3138 (Fam) Next Article Comments are only visible to subscribers.